A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum

Neurochemistry International

Volumn 34, Issue 4, 1999, Pages 345-350

  Kiss, J P ^a   Hennings, E C P ^a   Zsilla, G ^a   Vizi, E S ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Dopamine uptake; Microdialysis; Nitric oxide; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE TRANSPORTER; HOMOVANILLIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NOMIFENSINE;

ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; ELECTROCHEMISTRY; ENZYME INHIBITORS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICRODIALYSIS; NERVE TISSUE PROTEINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOMIFENSINE; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 0033018139     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00019-4     Document Type: Article

References (42)

1. Berman S.B., Zigmond M.J., Hastings T.G. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. Journal of Neurochemistry. 67:1996;593-600.
2. Black M.D., Matthews E.K., Humphrey P.P.A. The effects of a photosensitive nitric oxide donor on basal and electrically-stimulated dopamine efflux from the rat striatum in vitro. Neuropharmacology. 33:1994;1357-1365.
3. Bouyer J.J., Park D.H., Joh T.H., Pickel V.M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Research. 302:1984;267-275.
4. Buyukuysal L.R. Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. II: The role of voltage-dependent sodium channels, calcium channel activation, reverse transport mechanism, guanylate cyclase and endogenous glutamate. Fundamental and Clinical Pharmacology. 11:1997;528-536.
5. Cadet J.L., Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochemistry International. 32:1998;117-131.
6. Carlsson M., Carlsson A. Interaction between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends in Neurosciences. 13:1990;272-276.
7. Chaparro-Huerta, V., Beas-Zarate, C., Guerrero, M.U., Feria-Velasco, A., Nitric oxide involvement in regulating the dopamine transport in the striatal region of rat brain. Neurochemistry International 31 607-616.
8. Clineschmidt B.V., Martin G.E., Bunting P.R., Papp N.L. Central sympathomimetic activity of (+)-5-methyl-10-11-dihydro-5H-dibenzo (a.d)cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Development Research. 2:1982;135-145.
9. + in rat striatal slices. Neurochemistry International. 33:1998;35-40.
10. Farkas T., Wolf A.P., Jaeger J., Brodie J.D., Christman D.R., Fowler J.S. Regional brain glucose metabolism in chronic schizophrenia. Archives of General Psychiatry. 41:1984;293-300.
11. Fleckenstein A.E., Metzger R.R., Beyeler M.L., Gibb J.W., Hanson G.R. Oxygen radicals diminish dopamine transporter function in rat striatum. European Journal of Pharmacology. 334:1997;111-114.
12. Fleckenstein A.E., Metzger R.R., Wilkins D.G., Gibb J.W., Hanson G.R. Rapid and reversible effects of methamphetamine on dopamine transporters. Journal of Pharmacology and Experimental Therapeutics. 282:1997;834-838.
13. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the ethiology of schizophrenia. Neuroscience. 41:1991;1-24.
14. Graham W.C., Robertson R.G., Sambrook M.A., Crossman A.R. Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of Parkinsonism. Life Sciences. 47:1990;PL91-PL97.
15. Guevara-Guzman R., Emson P.C., Kendrick K.M. Modulation of in vivo transmitter release by nitric oxide and cyclic GMP. Journal of Neurochemistry. 62:1994;807-810.
16. Hauber W., Schmidt W.J. The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits. Behavioral Brain Research. 41:1990;161-166.
17. Kashihara K., Hamamura T., Okumura K., Otsuki S. Effect of MK-801 on endogenous dopamine release in vivo. Brain Research. 528:1990;80-82.
18. Kiss J.P., Toth E., Lajtha A., Vizi E.S. NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study. Brain Research. 641:1994;145-148.
19. Kiss J.P., Sershen H., Lajtha A., Vizi E.S. Inhibition of neuronal nitric oxide synthase potentiates the dimethylphenylpiperazinium-evoked carrier-mediated release of noradrenaline from rat hippocampal slices. Neuroscience Letters. 215:1996;115-118.
20. Kiss J.P., Windisch K., Balla A., Sershen H., Lajtha A. Dual effect of DMPP on the resting release of noradrenaline from rat hippocampal slices. Brain Research Bulletin. 43:1997;257-262.
21. 3H]dopamine release from rat striatal slices. Journal of Neuroscience Research. 35:1993;192-198.
22. 3H]glutamate by striatal synaptosomes. Journal of Neurochemistry. 63:1994;2108-2117.
23. Lopez-Gonzales M.A., Lucas M., Delgado F., Diaz P. The production of free radicals and nitric oxide in the rat cochlea. Neurochemistry International. 33:1998;55-59.
24. 3H]DA uptake and autoxidation in rat striatal slices. Experimental Neurology. 152:1998;88-94.
25. 3H]dopamine uptake. Brain Research. 641:1994;83-91.
26. Sándor N.T., Brassai A., Puskas A., Lendvai B. Role of nitric oxide in modulating neurotransmitter release from rat striatum. Brain Research Bulletin. 36:1995;483-486.
27. Schuman E.M., Madison D.V. Nitric oxide and synaptic function. Annual Reviews of Neurosciences. 17:1994;153-183.
28. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1:1992;133-152.
29. Segovia G., Mora F. Role of nitric oxide in modulating the release of dopamine, glutamate, and GABA in striatum of the freely moving rat. Brain Research Bulletin. 45:1998;275-279.
30. Silva M.T., Rose S., Hindmarsh J.G., Aislaitner G., Gorrod J.W., Moore P.K., Jenner P., Marsden C.D. Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by novel monosodium salt of 7-nitro indazole. British Journal of Pharmacology. 114:1995;257-258.
31. Silva M.T., Rose S., Hindmarsh J.G., Jenner P., Marsden C.D. L-arginine produces NO-independent increases in dopamine efflux in rat striatum. Neuroreport. 9:1998;149-152.
32. 3H]dopamine from rat striatum in vivo. Journal of Neurochemistry. 66:1996;131-137.
33. Strasser A., McCarron R.M., Ishii H., Stanimirovic D., Spatz M. L-arginine induces dopamine release from the striatum in vivo. Neuroreport. 5:1994;2298-2300.
34. 125I]RTI-121 quantitative autoradiography. Neurochemistry International. 32:1998;61-68.
35. Vizi E.S. Non-synaptic Interaction Between Neurons: Modulation of Neurochemical Transmission. 1984;Wiley, New York.
36. Vizi E.S., Labos E. Non-synaptic interactions at presynaptic level. Progresses in Neurobiology. 37:1991;145-163.
37. Vizi, E.S., Kiss, J.P., 1998. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and non-synaptic interactions. Hippocampus 8, 566-607.
38. Weinberger D.R., Berman K.F., Zec R.F. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. Archives of General Psychiatry. 43:1986;114-124.
39. West A.R., Galloway M.P. Intrastriatal infusion of (±)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats. Journal of Neurochemistry. 66:1996;1971-1980.
40. West A.R., Galloway M.P. Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms. Neuropharmacology. 36:1997;1571-1581.
41. Whitton P.S., Biggs C.S., Pearce B.R., Fowler L.J. Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neuroscience Letters. 142:1992;5-8.
42. Zhu X-Z., Luo L-G. Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. Journal of Neurochemistry. 59:1992;932-935.